CELSR2 and central nervous system cancer: To further explore potential molecular mechanisms of CELSR2 KD-induced proliferation inhibition in glioma cells, we performed data-independent acquisition (DIA) proteomics with protein extracts from cultured U87 MG cells transfected without (control) or with CELSR2-shRNA (CELSR2 KD).